Fitterfly has launched an online Prediabetes risk test which is an evidence-based, clinically validated tool for assessing an individual's risk of Prediabetes
The company said all doses achieved statistically significant reductions in body weight compared with placebo at 72 weeks
Clears major obesity endpoints at 80 weeks
Organizations that embrace it thoughtfully today will help shape a healthier tomorrow, for India and beyond
Eris Lifesciences posts sharp profit surge in FY26 driven by strong diabetes portfolio growth
All three dose levels, 4 mg, 9 mg and 12 mg, successfully met the primary and key secondary endpoints in 80 weeks
By leveraging digital screening and remote consultation, the medical community is moving beyond the confines of the clinic
The country’s strength lies not just in technology availability but in adoption behaviour
Dr. Reddy’s is the first company to receive Health Canada approval for generic Semaglutide Injection in Canada
Subscribe To Our Newsletter & Stay Updated
